Investigating Efficacy and Safety of Biphasic Insulin Aspart 50 Twice Daily Versus Biphasic Human Insulin 50 Twice Daily Both in Combination With Metformin in Chinese Subjects With Type 2 Diabetes Mellitus
Clinical trial NCT01892020 · COMPLETED
Trial details
- NCT number
- NCT01892020
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2013-06-01
- Primary completion
- 2014-05-01
- Enrollment
- 161
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.